Characterization of forced degradation products of tyrosine kinase inhibitor apatinib mesylate by LC-MS/MS and NMR with in silico toxicity assessment

Journal of Pharmaceutical and Biomedical Analysis 2026

View at publisher

Authors: Nadeem Shaikh, Rahul Khemchandani, Jayesh Shevatkar, Gananadhamu Samanthula

DOI: 10.1016/j.jpba.2026.117492

Cited by: 1

References: 26

Fields of Study & Subjects

Analytical Methods in Pharmaceuticals Chronic Myeloid Leukemia Treatments Colorectal Cancer Treatments and Studies

References 26